Halozyme Therapeutics Inc. Common Stock vs Kodiak Gas Services Inc. Common Stock — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $110.42 (market cap $12.58B), while Kodiak Gas Services Inc. Common Stock trades at $53.47 (market cap $5.42B). The key difference: Halozyme Therapeutics Inc. Common Stock is far larger — about 2.3× Kodiak Gas Services Inc. Common Stock's market cap, and Kodiak Gas Services Inc. Common Stock pays a 3.66% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and Kodiak Gas Services Inc. Common Stock for 1 Days on average.
| HALO | KGS | |
|---|---|---|
Market Cap | $12.58B | $5.42B |
Volume | 2,179,278 | 1,926,947 |
Sector | Health | Energy |
52-Week High | $115.22 | $76.27 |
52-Week Low | $61.63 | $32.95 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $14.49B | $8.10B |
Dividend Yield | — | 3.66% |
Trailing returns across standard periods
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →Kodiak Gas Services, Inc. is a Texas-based provider of large-horsepower contract natural gas compression services, operating a fleet of roughly 4.5 million revenue-generating horsepower for oil and gas producers and midstream companies across major US production basins, including the Permian, Eagle Ford, and DJ Basin.
Read more on KGS →